Concurrent radiotherapy and panitumumab after lymph node dissection and induction chemotherapy for invasive bladder cancer

In this prospective study we evaluated safety and efficacy of concurrent radiotherapy and panitumumab following neoadjuvant/induction chemotherapy (ICT) and pelvic lymph node dissection (PLND) as a bladder preserving therapy for invasive bladder cancer (BC).

Source: The Journal of Urology - October 12, 2018 Category: Urology & Nephrology Authors: Elisabeth E. Fransen van de Putte, Floris Pos, Barry Doodeman, Bas W.G. van Rhijn, Elsbeth van der Laan, Petra Nederlof, Michiel S. van der Heijden, Jolanda Bloos van der Hulst, Joyce Sanders, Annegien Broeks, J. Martijn Kerst, Vincent van der Noort, Simo Source Type: research